(150 mg Q4W) achieved complete response at Week 52 -- Rapid, profound and durable improvement in UAS7 as early as Week 1 with a ...

Candid’s launch is indicative of how growing interest in cell therapy for autoimmune diseases has expanded to include T cell engagers, too. Song has paid close attention. After selling RayzeBio to ...

Infusion-Related Reactions. VYVGART HYTRULO can cause infusion-related reactions. The most frequent symptoms and signs reported with efgartigimod alfa-fcab were high blood pressure, chills, shivering, ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced ...

Chronic urticaria occurs in about 0.1% of the population (Greaves, 2000). Patients previously classified as having chronic idiopathic or "ordinary" urticaria are now divided into two groups: 40% ...

While eczema does involve the immune system, most scientists wouldn’t classify eczema as an autoimmune disease. Autoimmune diseases occur when the body’s immune system attacks a specific part of the ...

Kris Aquino has returned to the Philippines after spending years abroad seeking treatment for her autoimmune conditions. The ...

Results from a confirmatory study show that dupilumab significantly reduces itch in patients with uncontrolled chronic spontaneous urticaria (CSU). Study C of the phase 3 LIBERTY-CUPID trial ...

A 4th was confirmed in late June of 2022 [1. Autoimmune Thyroiditis 2. Chronic Spontaneous Urticaria 3. Churg Strauss/EGPA—a rare, complicated form of vasculitis 4. Systemic Sclerosis].